Ikarian Capital »

Ptc Therapeutics I shares owned by Ikarian Capital

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $30M 494k 61.37
2023-09-30 $243k 11k 22.41
2023-03-31 $475k 9.8k 48.44

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Ptc Therapeutics I

Vanguard Group
Rtw Investments
BlackRock
Wellington Management Company
Henderson Group
Armistice Capital
Toronto-Dominion Bank
State Street Corporation
D. E. Shaw & Co
Geode Capital Management
Citadel Advisors
FMR
Leucadia National Corporation
Tang Capital Management
Pictet Asset Management Holding SA

View all funds holding Ptc Therapeutics I